The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1486
ISSUE1486
Med Lett Drugs Ther. 2016 Jan 18;58(1486):12
Disclosures
Objective(s)
The third sentence in the adverse effects section (Med Lett Drugs Ther 2015; 57:159) was incorrect. Cobicistat inhibits tubular secretion of creatinine, not reabsorption.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article